CEO Fordyce Marshall Buys Vera Therapeutics Shares at $2.90, Signal Strong Confidence
Vera Therapeutics insider buying shows CEO confidence amid promising kidney‑disease trial data—watch FDA filings and stock volatility.
3 minutes to read
VERA THERAPEUTICS INC
Insider Buying Signals Confidence in Vera Therapeutics’ Strategic Direction
Vera Therapeutics insider buys 5,000 shares at $3.94, far below market, signaling exec confidence in its immuno‑therapy pipeline and future growth.
4 minutes to read